mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.026 |
0.7 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.7 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |